Form 8-K - Current report:
SEC Accession No. 0000950170-24-087499
Filing Date
2024-07-30
Accepted
2024-07-30 06:59:17
Documents
12
Period of Report
2024-07-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K neog-20240730.htm   iXBRL 8-K 44039
2 EX-99.1 neog-ex99_1.htm EX-99.1 584683
  Complete submission text file 0000950170-24-087499.txt   772728

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT neog-20240730.xsd EX-101.SCH 29637
15 EXTRACTED XBRL INSTANCE DOCUMENT neog-20240730_htm.xml XML 4511
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 241154341
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)